Pfizer chief executive Dr Albert Bourla has recently said: “Based on everything I have seen so far, I would say that annual vaccinations… are likely to be needed to maintain a very robust and very high level of protection.”
Pfizer is already working on an updated version of its jab supposedly to deal with the ‘Omicron’ variant that could be ready in 100 days.
Pfizer will bank a minimum $35bn worth of Covid vaccine sales this year and has seen its share price rocket to all time highs.
Dr Bourla denies profiteering – saying the jab was the “cost of a takeaway meal” for richer countries but sold at no profit to low-income ones – but accepted rich countries such as the UK had placed orders early and availability had initially been limited.
Unity News Network (UNN) Staff Writer | To find out more details about our staff, please head to the About Us section on our website.
